ALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain
CNS Neuroscience & Therapeutics · 2025-05 · 31 (5)
DOI: 10.1111/cns.70440 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 19.05.2025. Verfasst von Zhiye Feng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China. Hauptthemen laut MEDLINE: Ferroptosis, Diabetic Neuropathies, Arachidonate 15-Lipoxygenase, Neurons. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shenzhen Municipality.
Abstract (Originalsprache)
Background
Diabetic peripheral neuropathic pain (DPNP) is one of the most common complications in diabetic patients. Current treatment strategies primarily focus on blood glucose control and pain relief, but they often yield limited effects. Ferroptosis, a regulated form of cell death driven by lipid peroxidation and iron imbalance, plays a crucial role in various diseases, including neuropathic pain.
Methods
In this study, we employed a combined bioinformatics and machine learning approach to identify genes most strongly associated with DPNP and ferroptosis. Subsequently, we established a DPNP mouse model via streptozotocin (STZ) injection and a high‐glucose‐induced SH‐SY5Y cell injury model. ALOX15 was knocked down in the in vitro model using siRNA transfection.
Results
Bioinformatics analysis identified ALOX15 as a hub gene linking DPNP and ferroptosis. In both in vivo and in vitro DPNP models, ALOX15 expression was significantly upregulated and correlated with ferroptosis biomarkers. Knockdown of ALOX15 in the cellular model mitigated high‐glucose‐induced ferroptosis, reduced lipid peroxidation and free iron ion accumulation, and restored cell viability.
Conclusion
In conclusion, ALOX15 contributes to the onset and progression of DPNP by promoting ferroptosis, and its knockdown effectively suppresses ferroptosis, providing a novel target and strategy for DPNP treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
- Department of Critical Care Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, China.
- Zhongshan Hospital of Traditional Chinese Medicine, Zhongshan, China.
- Shenzhen LuoHu People's Hospital, Shenzhen, China.
- Department of Anesthesiology, Shenzhen Children's Hospital, Shenzhen, China.
ORCID-Profile: Zhongjie Liu
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Shenzhen Municipality
Zitieren
APA
Feng, Z., Li, F., Lin, Z., Liu, J., Chen, X., Yan, W., & Liu, Z. (2025). ALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain. CNS Neuroscience & Therapeutics, 31(5). https://doi.org/10.1111/cns.70440
Vancouver
Feng Z, Li F, Lin Z, Liu J, Chen X, Yan W, et al. ALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain. CNS Neuroscience & Therapeutics. 2025;31(5). doi:10.1111/cns.70440
BibTeX
@article{Feng2025,
author = {Feng, Zhiye and Li, Fuye and Lin, Zhiqiang and Liu, Jian and Chen, Xi and Yan, Wenxu and Liu, Zhongjie},
title = {ALOX15‐Mediated Neuron Ferroptosis Was Involved in Diabetic Peripheral Neuropathic Pain},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {5},
doi = {10.1111/cns.70440}
}
EUVIMED